Choi JG, Winn AN, Skandari MR, Franco MI, et al. First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists : A Cost-Effectiveness Study. Ann Intern Med 2022 Oct 4. doi: 10.7326/M21-2941.
PMID: 36191315